S&P ASX All Technology

US Dollar vs AUD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

QNRX Quoin Pharmaceuticals Ltd

0.2841

-0.0084 (-2.87%)

Last Updated: 04:14:55

Delayed by 15 minutes

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Quoin Pharmaceuticals (NASDAQ:QNRX)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Quoin Pharmaceuticals Charts.

Quoin Pharmaceuticals (NASDAQ:QNRX)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Quoin Pharmaceuticals Charts.

Quoin Pharmaceuticals Ltd News

Quoin Pharmaceuticals to Announce Fourth Quarter and Full-Year 2024 Financial Results on Thursday, March 13, 2025
Friday 7 March 2025 (5 days ago) • GlobeNewswire Inc.

Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Topical Rapamycin Formulations to Treat Rare Disease Indications
Tuesday 4 March 2025 (1 week ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 28 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Quoin Pharmaceuticals Announces Highly Positive ‘Whole Body’ Clinical Data from Ongoing Pediatric Netherton Syndrome Study
Thursday 27 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Quoin Pharmaceuticals Launches First Episode of “NETHERTON NOW” Video Series to Raise Awareness for Netherton Syndrome
Tuesday 25 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 5 February 2025 (1 month ago) • Edgar (US Regulatory)

Quoin Pharmaceuticals Launches ‘NETHERTON NOW’ Campaign to Raise Awareness of Netherton Syndrome, a Rare Genetic Disease with No Approved Treatment or Cure
Tuesday 4 February 2025 (1 month ago) • GlobeNewswire Inc.

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Wednesday 29 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 24 January 2025 (2 months ago) • Edgar (US Regulatory)

Quoin Pharmaceuticals Announces Further Clinical Evidence of QRX003 Effectiveness in Netherton Syndrome
Friday 24 January 2025 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 17 January 2025 (2 months ago) • Edgar (US Regulatory)

Quoin Pharmaceuticals Announces Further Positive Clinical Data from Ongoing Pediatric Netherton Syndrome Study
Wednesday 15 January 2025 (2 months ago) • GlobeNewswire Inc.

More Quoin Pharmaceuticals Ltd News Articles

Commonwealth Bank Of Aus...

Australian SE All Ordina...

AUD vs US Dollar

National Australia Bank

Sterling vs AUD

Newcrest Mining

Gold vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions